As increased ROS reflects high metabolic activity in tumour cells and ROS determines RB1CC1 expression (Figure 1A and17), the upregulation of RB1CC1 in lung cancer can be explained by the high malignant property. This evidence concerns the gene RB1CC1 and neoplasm.